CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
9.47
-0.43 (-4.34%)
Dec 3, 2024, 1:44 PM EST - Market open
CorMedix Employees
As of December 31, 2023, CorMedix had 83 total employees, including 82 full-time and 1 part-time employees. The number of employees increased by 42 or 102.44% compared to the previous year.
Employees
83
Change (1Y)
42
Growth (1Y)
102.44%
Revenue / Employee
$147,738
Profits / Employee
-$556,005
Market Cap
574.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Fulgent Genetics | 1,184 |
Talkspace | 472 |
Phathom Pharmaceuticals | 452 |
Verve Therapeutics | 255 |
Esperion Therapeutics | 240 |
ProKidney | 163 |
EyePoint Pharmaceuticals | 121 |
Mind Medicine (MindMed) | 57 |
CRMD News
- 7 days ago - CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products - GlobeNewsWire
- 25 days ago - Stock Picks From Seeking Alpha's October 2024 New Analysts - Seeking Alpha
- 4 weeks ago - CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - GlobeNewsWire
- 4 weeks ago - CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - CorMedix 2.0: New Leadership, New Approval, New Focus - Seeking Alpha
- 5 weeks ago - Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
- 5 weeks ago - CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - GlobeNewsWire